search icon

    Market Snapshot

    • S&P Futures

      3,809.5

    • Dow Futures

      30,868

    • Nasdaq Futures

      11,633.25

    blog search icon

    Aileron Therapeutics, Inc.

    (NASDAQ:ALRN)

    $0.26

    $-0.04

    -13.39%

    Aileron Therapeutics, Inc. Chart

    ALRN Stock Price Today

    Aileron Therapeutics, Inc. (ALRN) stock declined over -13.39% intraday to trade at $0.26 a share on NASDAQ. The stock opened with a loss of -31.58% at $0.305 and touched an intraday high of $0.305, falling -13.33% against the last close of $0.3. The stock went to a low of $0.252 during the session.

    Stock Snapshot

    $0.3

    Prev. Close

    24.89 Million

    Market Cap

    $0.252

    Day Low

    $0.305

    Open

    90.67 Million

    Number of Shares

    $0.305

    Day High

    -

    P/E ratio

    -0.30

    EPS (TTM)

    0.51

    Cash Flow per Share

    0.24

    Free Float in %

    0.55

    Book Value

    1,059,776

    Volume

    Aileron Therapeutics, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-30$0.305$0.305$0.252$0.261,053,796
    2022-06-29$0.38$0.38$0.263$0.33,372,300
    2022-06-28$0.438$0.438$0.4$0.412139,000
    2022-06-27$0.439$0.439$0.4$0.42179,100
    2022-06-24$0.406$0.45$0.397$0.397349,000
    2022-06-23$0.39$0.443$0.39$0.419330,700
    2022-06-22$0.4$0.418$0.39$0.397173,100
    2022-06-21$0.391$0.414$0.39$0.401144,700
    2022-06-17$0.388$0.45$0.375$0.418586,800
    2022-06-16$0.397$0.419$0.37$0.39165,900

    Contact Details

    285 Summer Street
    Suite 101
    Boston, MA 02210
    United States

    Webiste:ALRN

    617 995 0900

    Company Information

    Employees-

    Beta2.34

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine, or Ara-C, in patients with MDS; and a Phase 2a combination trial of ALRN-6924 and palbociclib in patients with tumors harboring MDM2 amplifications co-amplifications, as well as for patients with p53-mutated small cell lung cancer that has completed Phase 1b clinical trial. Aileron Therapeutics, Inc. has a license agreement with Dana-Farber Cancer Institute and Harvard College; and Umicore Precious Metals Chemistry USA, LLC. The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc. in February 2007. Aileron Therapeutics, Inc. was incorporated in 2001 and is based in Boston, Massachusetts.

    Frequently Asked Questions

    icon

    What is the current Aileron Therapeutics, Inc. (ALRN) stock price?

    Aileron Therapeutics, Inc. (NASDAQ: ALRN) stock price is $0.26 as of the last check on Thursday, June 30. During the trading session, ALRN stock reached the peak price of $0.305 while $0.252 was the lowest point it dropped to.

    icon

    ALRN's industry and sector of operation?

    The NASDAQ listed ALRN is part of Biotechnology industry that operates in the broader Health Care sector. Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States.

    icon

    Who are the executives of ALRN?

    Dr. Manuel C. Aivado
    Pres, CEO & Director
    Mr. Richard J. Wanstall M.B.A.
    SVP, CFO & Treasurer
    Dr. Vojislav Vukovic M.D., Ph.D.
    Sr. VP & Chief Medical Officer
    Dr. D. Allen Annis Ph.D.
    Sr. VP of Research

    icon

    What is the ALRN stock price today?

    ALRN stock traded closed the last session at $0.26, which is $-0.04 or -13.39% lower than its previous close of $0.3. ALRN's current trading price is -1.25% lower than its 52-week high of $1.34 where as its distance from 52-week low of 0.26% is -80.60%.

    icon

    How many employees does ALRN have?

    Number of ALRN employees currently stands at -. ALRN operates from 285 Summer Street, Suite 101, Boston, MA 02210, United States.

    icon

    Link for ALRN official website?

    Official Webiste of $ALRN is: https://www.aileronrx.com

    icon

    How do I contact ALRN?

    ALRN could be contacted at ALRN operates from 285 Summer Street, Suite 101, Boston, MA 02210, United States, or at phone #617 995 0900 and can also be accessed through its website.

    icon

    How many shares of ALRN are traded daily?

    ALRN stock volume for the day was 1,059,776 shares while in the previous session number of ALRN shares traded was 1,053,796 . The average number of ALRN shares traded daily for last 3 months was 335.84 Thousands.

    icon

    How much did ALRN change today?

    The percentage change in ALRN stock occurred in the recent session was -13.39% while the dollar amount for the price change in ALRN stock was $-0.04.

    icon

    What price range ALRN stock been trading in?

    In the recent session, the day high for ALRN stock was $0.305 while the low for ALRN stock touched on the day was $0.252.

    icon

    What is the market cap of ALRN currently?

    The market value of ALRN currently stands at 24.89 Million with its latest stock price at $0.26 and 90.67 Million of its shares outstanding.